ArticleDrug design, development and therapy2023

Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy.

Beibei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.